News
As new figures show how obesity is rising among children and teenagers, doctors debate if weight loss jabs are the answer ...
Pregnant women with metabolic dysfunction-associated steatotic liver disease (MASLD) have an increased risk of giving birth prematurely and the risk increase cannot be explained by obesity, according ...
Scientists are continuing to find evidence that GLP-1 medications can temper cravings for alcohol and other drugs.
Naim Alkhouri, MD, spoke to the potential for glucagon-like peptide-1 (GLP-1) receptor agonists to transform the treatment ...
Findings showed a 13.6% reduction in body weight in the semaglutide 25mg group compared with a 2.2% reduction in the placebo group.
A novel investigational endoscopic procedure targeting the duodenum appears beneficial in improving glycemic parameters in ...
We expected miracles; what we got was a legal minefield. As GLP-1 drugs like Ozempic reshape bodies and bottom lines, a ...
Chances are, you haven’t heard of metabolic dysfunction–associated steatohepatitis (MASH)—but you’ve almost definitely heard ...
Mounjaro and Ozempic are two medications that can help with diabetes and weight management. But is there a winner in the ...
Dosing complete in the first two cohorts of INLIGHT trial in obesity of WVE-007 (INHBE siRNA), designed to induce healthy weight loss by reducing fat without impacting muscle; clinical data on track ...
Dosing complete in the first two cohorts of INLIGHT trial in obesity of WVE-007 (INHBE siRNA), designed to induce healthy weight loss by reducing fat without impacting muscle; clinical data on track ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results